1. Some Assembly Required: Joint Replacement Richard J Friedman, MD Charleston Orthopaedic Associates Charleston, SC

5. Total Hip Arthroplasty l Alternate bearing surfaces l MIS l Hip resurfacing

6. Total Knee Arthroplasty l State of the Art

7. Total Shoulder Arthroplasty l Reverse total shoulder arthroplasty

8. Patient Management l Anaesthesia l Perioperative pain control l VTE Prophylaxis l Perioperative planning and discharge l Long-term results

9. Arthroplasty l Latinarth - joint l Greekplastica - molding

10. Total Joint Arthroplasty l First successful THA 1960 l Many improvements l Over 800,000 done annually in USA l Highly successful outcomes

11. Total Joint Arthroplasty l Osteoarthritis l Post-traumatic arthritis l Osteonecrosis l Inflammatory arthritis

12. Indications l Pain l Disability l Health status l Age

13. Evaluation l History l Physical Examination l Radiographs l CT, MRI, bone scan, blood tests

14. Conservative Treatment l Heat l NSAID l Physical therapy

15. Expectations l Excellent pain relief l Improvements in ADLs l Increased physical activity

16. Preoperative Evaluation l Medical clearance l Tests l Blood donation l Weight loss l Dental Evaluation l Urinary evaluation l Social planning

17. Alternate Bearing Surfaces l THA in younger and higher-demand patients l Long-term fixation of metal implants l Long-term failure due to PE wear, osteolysis and aseptic loosening. l Develop bearing surface that can function at high level and prolong life of well-fixed components

20. Ceramic THA l Mid-term study has demonstrated efficacy and safety of a ceramic on ceramic bearing surface compared to the standard ceramic/PE surface. l No failures or complications related to the bearing surfaces.

21. Ceramic THA l Improved wear and biocompatibility with a ceramic/ceramic bearing surface may increase implant longevity. l Further follow-up is indicated to determine the long-term outcome.

26. Rehabilitation l FWB immediately l Range of motion, strengthening exercises l Progress as quickly as possible

27. Minimal Invasive Surgery l Single 3-4 inch incision l Two 2 inch incisions l Shorter surgery time l Less blood loss l Quicker rehabilitation l Improved functional outcome

29. Minimal Incision Surgery l Major marketing ploy l No differences in –blood loss –surgery time –pain levels –functional outcomes

30. HipResurfacing l Younger more active patients l Higher expectations l Proven benefit/cost ratio l Continuing to push the envelope

31. Theoretical Advantages of Hip Resurfacing Minimal bone resection  Minimal bone resection  Normal femoral loading  Maximum proprioceptive feedback  Restores natural anatomy :  offset, leg length  anteversion  Minimal risk of dislocation  Easier revision

32. Resurfacing THA –Largest experience with Birmingham –Used globally since 1997 with more than 100,000 implanted –Approved by the FDA in March 2006 –Corin 2000 marketed by Stryker approved in Jun 2007

33. Typical Candidate –Patients experiencing hip pain due to OA, RA, DDH or AVN –Adults under age 60 for whom THA may not be appropriate due to an increased level of physical activity –Active adults over age 60 may be candidates, depending on their bone quality

34. Patient Selection Criteria l Hip resurfacing is most appropriate for physically active patients with good bone quality and adequate femoral and acetabular bone stock. l Such patients will generally be under the age of 65. l OA l Strong Heavy Male l Women < 50 years l Men < 60 years l High Expectation l High activity level

35. Indications l Primary osteoarthritis. l Post traumatic OA. l Secondary OA, e.g. DDH, SCFE, Perthes’ disease. l AVN of the femoral head if remaining bone stock is adequate. l Inflammatory arthritis if bone quality is adequate. l Any patient with a deformity of the femur or hardware that would prevent insertion of a stemmed femoral component. l Patients with a high risk of dislocation.

36. Conventional THA

37. Resurfacing THA

38. Key Benefits –Large head size –Alternate bearing surface –Bone conservation

39. Bone Conservation –Revises to a primary –If patients need revision surgery, they don’t get a revision implant –The revision procedure would be the same THA they would otherwise have received

40. Postoperative Therapy –Rehabilitation protocol similar to THA patients –Weight bearing as tolerated –Motion and strengthening exercises and gradual progression to normal activities.

41. Resurfacing Survivorship

49. Resurfacing THA l Quality of life issues. l Conservative approach. l No bridges burned. l Careful patient selection. l Meticulous surgical technique.

50. TKA State-of-the Art l Posterior cruciate retention l Posterior cruciate sacrificing l Both achieve 95%+ success at 10 yrs l Metal/PE articulation

73. Reverse TSA l What is it? l Why use it? l Who uses it? l When should it be used? l Where can it get you?

74. Shoulder Biomechanics arm weight = 5 kg Arm elevation means that Arm elevation means that the deltoid must counteract effect of arm weight Arm elevation means that Arm elevation means that the deltoid must counteract effect of arm weight The center of rotation is The center of rotation is located in the humeral head located in the humeral head The center of rotation is The center of rotation is located in the humeral head located in the humeral head

75. Shoulder Biomechanics arm weight = 5 kg l A stable fulcrum is created by the RC l COR creates ideal moment for deltoid to elevate arm l RC contributes to abduction >90˚ l A stable fulcrum is created by the RC l COR creates ideal moment for deltoid to elevate arm l RC contributes to abduction >90˚

76. Problem l Massive rotator cuff tears l Instability l Glenohumeral arthritis

77. PathologyPathology l Weakness l Instability l Incongruous joint surfaces joint surfaces l Bone loss

78. Treatment Objectives l Restore stability to GH joint l Provide smooth articulating surfaces l Replace bone loss l Optimize remaining cuff muscles, restoring rotational strength l Restore stability to GH joint l Provide smooth articulating surfaces l Replace bone loss l Optimize remaining cuff muscles, restoring rotational strength

79. Reverse TSA l Kessel, Kölbel, Fenlin, Gerard, Liverpool, Neer & Averill

80. Reverse TSA l Kessel, Kölbel, Fenlin, Gerard, Liverpool, Neer & Averill

81. Reverse TSA l No reliable surgical solution to restore anatomy prior to reverse TSA l Unconstrained arthroplasty may resurface arthritic humeral head but instability will remain l Prosthetic design with increased constraint can potentially help instability

82. Reverse TSA l Semi-constrained l Provides stable fulcrum l Multiple options for center of rotation l Ability to maintain anatomic center of rotation l Fixed angle central lag screw for fixation l 4 locking 5.0mm peripheral screws

83. Indications l Glenohumeral OA with massive cuff tear. l Failed cuff repairs with static instability. l Massive irreparable rotator cuff tear. l Post-traumatic arthritis w/wo static instabilty. l Malunited and nonunited fractures. l Primary fracture treatment in the elderly. l No other satisfactory option available.

84. Indications l Failed hemiarthoplasty. l Prosthetic instability. l Rotator cuff insufficiency. l Glenoid bone reconstruction. l Rheumatoid shoulder. l Neoplasm. l No other satisfactory option available.

85. Surgical Lessons l Place glenoid baseplate low and tilt inferiorly. l Inferior capsular release important. l Bone graft on glenoid behind baseplate for wear.

103. Postoperative Protocol l Much less intense than conventional TSA. l Sling for 4-6 weeks depending on indication. l Passive pendulums and Codmans followed by AAROM. l After sling, often ADLs and no formal PT.

104. Clinical Results l Pain significantly less. l ASES, Constant scores increased. l Patient satisfaction high. Sirveaux JBJS 2000, Frankle JBJS 2005, Werner JBJS 2005, Boileau JSES, 2005Sirveaux JBJS 2000, Frankle JBJS 2005, Werner JBJS 2005, Boileau JSES, 2005

120. Complications l Must separate primary and revision cases. l Overall 16% complication rate. l Revision rate 3X primary rate. l Rates similar to conventional TSA. l Humble learning curve.

121. Complications l Instability l Infection l Postoperative fracture

126. Survivorship l Survivorship 98% at 7 years with RSP. l Survivorship 91% at 10 years with Delta III.

127. Patient Management l Anaesthesia l Perioperative pain control l VTE Prophylaxis l Long-term results

128. Anaesthesia l General l Regional l Blocks - sciatic, femoral, lumbar plexus, interscalene

129. Pain Management l Multimodal pain management l Anaesthesia blocks l Cox 2 NSAIDs l Long acting narcotics

130. Venous Thromboembolism l All THA and TKA need prophylaxis l Guidelines recommend LMWH, warfarin or anti-Xa agents. l Minimum 2 weeks l Consider extended prophylaxis (4weeks) in patients with increased risk factors

131. Long-term results l Cost-benefit ratio high l Quality of life issues l THA 85% doing well at 20 years l TKA 90% doing well at 20 years l TSA >90% doing well at 20 years

132. Thank You